Jaguar Health, Inc. Quarterly Cost of Revenue in USD from Q1 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Jaguar Health, Inc. quarterly/annual Cost of Revenue history and growth rate from Q1 2015 to Q3 2024.
  • Jaguar Health, Inc. Cost of Revenue for the quarter ending September 30, 2024 was $541K, a 5.25% increase year-over-year.
  • Jaguar Health, Inc. Cost of Revenue for the twelve months ending September 30, 2024 was $2.09M, a 13% increase year-over-year.
  • Jaguar Health, Inc. annual Cost of Revenue for 2023 was $2.04M, a 0.89% increase from 2022.
  • Jaguar Health, Inc. annual Cost of Revenue for 2022 was $2.02M, a 13.5% decline from 2021.
  • Jaguar Health, Inc. annual Cost of Revenue for 2021 was $2.33M, a 28.9% decline from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $2.09M $541K +$27K +5.25% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $2.06M $427K -$64K -13% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $2.12M $430K +$85K +24.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $2.04M $687K +$192K +38.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $1.85M $514K -$99K -16.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $1.94M $491K +$35K +7.68% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $1.91M $345K -$110K -24.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $2.02M $495K +$26K +5.54% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $1.99M $613K -$4K -0.65% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $2M $456K -$208K -31.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $2.21M $455K -$128K -22% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $2.33M $469K -$320K -40.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-24
Q3 2021 $2.65M $617K -$167K -21.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $2.82M $664K -$367K -35.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-22
Q1 2021 $3.19M $583K -$93K -13.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $3.28M $789K +$46K +6.19% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 $3.23M $784K -$164K -17.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-17
Q2 2020 $3.4M $1.03M -$229K -18.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $3.63M $676K -$189K -21.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $3.82M $743K -$214K -22.3% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 $4.03M $948K +$211K +28.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $3.82M $1.26M +$652K +107% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $3.17M $865K +$401K +86.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 $2.77M $957K +$324K +51.1% Oct 1, 2018 Dec 31, 2018 10-K 2020-04-03
Q3 2018 $2.44M $737K +$531K +257% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $1.91M $608K +$583K +2355% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $1.33M $464K +$448K +2775% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-21
Q4 2017 $880K $633K +$618K +4094% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-10
Q3 2017 $262K $206K +$196K +1992% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-19
Q2 2017 $65.9K $24.8K +$16.1K +187% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 $49.7K $16.1K -$2.22K -12.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $52K $15.1K -$20.5K -57.5% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-09
Q3 2016 $72.4K $9.86K -$26.8K -73.1% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-20
Q2 2016 $99.2K $8.64K -$8.32K -49% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $108K $18.4K -$15.9K -46.4% Jan 1, 2016 Mar 31, 2016 10-Q/A 2017-06-23
Q4 2015 $123K $35.6K Oct 1, 2015 Dec 31, 2015 10-K 2017-02-15
Q3 2015 $36.6K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 $17K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 $34.3K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.